Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy-Reference-Cited by-同舟云学术

Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy

Published:2012-02 Issue:2 Volume:23 Page:388-394
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Coudert B.,Ciuleanu T.,Park K.,Wu Y.-L.,Giaccone G.,Brugger W.,Gopalakrishna P.,Cappuzzo F.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/2/388/550965/mdr125.pdf

Reference28 articles.

1. American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer;Azzoli;J Clin Oncol,2009

2. Erlotinib in previously treated non–small-cell lung cancer;Shepherd;N Engl J Med,2005

3. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up;D'Addario;Ann Oncol,2009

4. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BBR.21;Bezjak;J Clin Oncol,2006

5. Salvage therapy for advanced non-small cell lung cancer: factors influencing treatment selection;Ramalingam;Oncologist,2006

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer;Translational Lung Cancer Research;2022-05

2. Sarcopenia is a predictive marker for response to erlotinib in patients with lung adenocancer;CLIN CANCER INVESTIG;2021

3. Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells;Translational Cancer Research;2020-09

4. Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis;PLOS ONE;2020-07-14

5. Therapeutic Targeting of Cancer Cells;Abeloff's Clinical Oncology;2020